scispace - formally typeset
J

Joseph L. Izzo

Researcher at University at Buffalo

Publications -  232
Citations -  53804

Joseph L. Izzo is an academic researcher from University at Buffalo. The author has contributed to research in topics: Blood pressure & Systolic hypertension. The author has an hindex of 46, co-authored 229 publications receiving 51755 citations. Previous affiliations of Joseph L. Izzo include Erie County Medical Center & LSU Health Sciences Center New Orleans.

Papers
More filters
Journal ArticleDOI

Effect of Intensive Versus Standard Blood Pressure Lowering on Diastolic Function in Patients With Uncontrolled Hypertension and Diastolic Dysfunction

TL;DR: The degree of improvement in annular relaxation velocity was associated with the extent of systolic blood pressure reduction, and patients with the lowest achieved systolics blood pressure had the highest final diastolic relaxation velocities.
Journal ArticleDOI

Normalization of hypertensive responses during ambulatory surgical stress by perioperative music.

TL;DR: The perceived stress of ambulatory surgery in geriatric patients is associated with a clinical hypertensive response that is ameliorated by self-selected perioperative music, which also decreases perceived stress and increases patients' sense of personal control and well-being.
Journal ArticleDOI

Mechanisms and management of hypertensive heart disease: from left ventricular hypertrophy to heart failure

TL;DR: This review describes an integrated model of the natural history, pathogenesis, and drug treatment of hypertensive heart disease that is consistent with the recommendations of the Seventh Report of the Joint National Committee on the Prevention, Detection, Evaluation, and Treatment of High Blood Pressure.
Journal ArticleDOI

Vasodilatory Effects of Troglitazone Improve Blood Pressure at Rest and During Mental Stress in Type 2 Diabetes Mellitus

TL;DR: Improved insulin resistance rather than an improved glycemic control is associated with lower resting and stress BP values in patients with DM, and insulin sensitizers may offer potential therapeutic advantage in subjects with DM with elevated BP.